Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
American Society of Hematology
2017
|
Summary: |
---|